1.
Paola S-RC, Fabián M-HJ, Jordi G-C, Rodrigo R-S, Jorge G-H, Sonia C-C, et al. Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. acmcr [Internet]. 2020 Nov. 20 [cited 2026 Jun. 15];4(6):1108-15. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422